NewEdge Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.4K | Buy |
2,285
+800
| +54% | +$7.5K | ﹤0.01% | 2935 |
|
|
2025
Q1 | $10.6K | Buy |
+1,485
| New | +$10.6K | ﹤0.01% | 3082 |
|
|
2024
Q4 | – | Sell |
-300
| Closed | -$6.17K | – | 3982 |
|
|
2024
Q3 | $6.17K | Buy |
+300
| New | +$6.17K | ﹤0.01% | 3090 |
|
|
2024
Q2 | – | Sell |
-40
| Closed | -$1.1K | – | 3946 |
|
|
2024
Q1 | $1.1K | Buy |
+40
| New | +$1.1K | ﹤0.01% | 3480 |
|
|
2023
Q4 | – | Sell |
-3
| Closed | -$95 | – | 3846 |
|
|
2023
Q3 | $95 | Sell |
3
-333
| -99% | -$10.5K | ﹤0.01% | 3368 |
|
|
2023
Q2 | $13.7K | Sell |
336
-183
| -35% | -$7.46K | ﹤0.01% | 2503 |
|
|
2023
Q1 | $19.3K | Sell |
519
-725
| -58% | -$27K | ﹤0.01% | 2354 |
|
|
2022
Q4 | $28.7K | Buy |
+1,244
| New | +$28.7K | ﹤0.01% | 1984 |
|